Trials / Completed
CompletedNCT00429663
A Multicenter Randomized Trial Comparing IM Nails and Plate Fixation in Distal Femur Fractures
Study of Locked Plates Versus Intramedullary Nails in Distal Femur Fractures: A Multicenter Randomized Trial Comparing IM Nails and Plate Fixation (S.O.L.V.E.D)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 160 (actual)
- Sponsor
- Boston Medical Center · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This study looks at two (2) types of surgical treatments and hopes to answer the question, "which is the best way to surgically treat a distal femur fracture?" Both procedures being studied are standard of care (used routinely) and use FDA approved devices. All medical and surgical treatment will be the same for participants as non-participants.
Detailed description
The study is a randomized controlled multicenter trial in which individuals sustaining a fracture of the supracondylar (metaphyseal) region of the distal femur will be operatively managed by one of two strategies. The first strategy involves fixation of the fracture with a reamed, interlocking intramedullary nail (Nail Group). The second treatment strategy involves open reduction and internal fixation of the fracture with a locking periarticular plate (Plate Group). The null hypothesis of the study is that there will be no difference in the two groups with respect to the primary and secondary outcome measures. To the degree possible, patients in the two groups will receive post-operative care according to the same standards and protocols.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | reamed, interlocking intramedullary nail | Standard of care device for femur fracture repair |
| DEVICE | locking periarticular plate | Standard of care device for femur fractures |
Timeline
- Start date
- 2007-02-01
- Primary completion
- 2014-12-01
- Completion
- 2016-12-01
- First posted
- 2007-02-01
- Last updated
- 2017-05-11
- Results posted
- 2017-02-09
Locations
22 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00429663. Inclusion in this directory is not an endorsement.